What does stable disease mean on my Bladder Cancer scan results

Bladder CancerMay 18, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding "Stable Disease" on Your Bladder Cancer Scan

Great question—this is an important term to understand when reviewing your scan results. Let me break down what "stable disease" means and why it matters for your care.

What "Stable Disease" Means

Stable disease means that your cancer has not significantly grown or shrunk since your last scan. The tumors are essentially staying about the same size, and no new tumors have appeared. It's a middle ground between two other possible outcomes:

  • Response/Improvement: Cancer shrinks
  • Progression: Cancer grows or new tumors develop
  • Stable Disease: Cancer stays roughly the same size

Why This Matters for Bladder Cancer

According to the NCCN Guidelines for Bladder Cancer, how your disease responds to treatment is a critical factor in determining your next steps. The guidelines specifically note that after treatment, doctors reassess your tumor status to decide whether to:

  • Continue current treatment
  • Switch to a different approach
  • Consider additional therapies
  • Adjust your follow-up schedule

For bladder cancer specifically, stable disease can mean different things depending on your stage and what treatment you've received:

If you have muscle-invasive bladder cancer being treated with chemotherapy or chemoradiotherapy, the NCCN Guidelines indicate that stable disease may prompt your doctor to consider whether consolidation therapy (additional treatment to target remaining disease) or cystectomy (surgical removal of the bladder) might be beneficial.

If you have non-muscle invasive disease, stable disease typically means your current treatment plan is working to prevent progression, and continued surveillance with regular cystoscopy (camera examination of the bladder) remains important.

Important Context

It's crucial to understand that "stable" doesn't necessarily mean "good" or "bad"—it's simply a description of what the scan shows. The clinical significance depends on:

  • Your specific stage of bladder cancer
  • What treatment you've received (surgery, chemotherapy, radiation, immunotherapy)
  • How long you've had stable disease (stable for 3 months vs. 2 years has different meanings)
  • Your overall health and treatment tolerance
  • Whether this is your first scan or a follow-up

Questions to Ask Your Oncologist

Since stable disease can mean different things in different situations, here are specific questions that will help you understand YOUR situation:

  1. "Is stable disease a good outcome for my specific stage and treatment plan?" (Your doctor can explain whether this is the expected goal or if they were hoping for shrinkage)

  2. "What does this mean for my next treatment steps?" (Will you continue the same treatment, switch approaches, or move to surveillance?)

  3. "How often will we scan to monitor for changes?" (This helps you understand the follow-up plan)

  4. "Are there any concerning features in the stable disease, such as location or size?" (Some stable tumors may still warrant intervention)

  5. "What would we consider progression, and what would we consider improvement?" (This helps you understand the range of possible outcomes)

Moving Forward

According to the NCCN Guidelines, your care team will use your scan results along with other clinical information to guide treatment decisions. The guidelines emphasize that reassessment of disease activity should happen regularly, especially if you develop new or worsening symptoms.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: